Industry Overview

Dental bone graft substitutes market was valued at $0.9 billion in 2025 and is projected to reach $1.3 billion by 2035, growing at a CAGR of 4.2% during the forecast Period (2026-2035). The market growth is driven by rising dental implant demand, aging populations, increased periodontal disease, and cosmetic dentistry trends, alongside technological advances like bioactive materials. Key factors boosting this market include the need for bone regeneration after tooth loss, oral cancer surgery, and better dental diagnostics, while high costs and complex regulations remain challenges. Xenografts currently lead, but synthetics and biologics are rising, with major players like Straumann, Dentsply Sirona, and Johnson & Johnson competing.

Market Dynamics

Rising Prevalence of Dental Disorders and Implant Procedures

One of the most significant drivers of the global dental bone graft substitutes market is the increasing prevalence of dental disorders including periodontal disease, tooth loss, and edentulism which necessitate restorative and regenerative treatments. As periodontal diseases affect a substantial proportion of the adult population, the need for procedures that restore lost bone volume has grown considerably. These substitutes are essential in many dental implant procedures to ensure adequate bone support for implants and improve long-term stability. Consequently, the rising number of dental implant surgeries worldwide, driven by both clinical necessity and aesthetic demands, directly fuels the adoption of bone graft substitutes.

Aging Population and Geriatric Oral Health Needs

Another major market driver is the expanding global geriatric population, which is more susceptible to dental bone loss due to age-related conditions such as tooth loss, bone resorption and chronic periodontal disease. Older adults increasingly seek dental restoration procedures, including implants and bone augmentation treatments, to maintain oral function and quality of life. As the proportion of elderly individuals continues to rise in many regions, such as North America, Europe, and parts of Asia-Pacific, demand for dental bone graft substitutes grows correspondingly. This demographic trend is boosting procedural volumes and overall market expansion.

Technological Advancements and Innovations in Biomaterials

Technological innovation in dental biomaterials and surgical techniques is driving the adoption of bone graft substitutes by improving clinical outcomes and expanding treatment possibilities. Advancements include the development of synthetic grafts with enhanced biocompatibility, bioactive materials, 3D-printed scaffold structures, and user-friendly formats such as injectable or ready-to-use composites. These innovations address limitations associated with traditional graft options (like autografts), reduce morbidity, and enhance bone regeneration efficacy. The integration of digital dentistry workflows and personalized treatment planning further supports the use of advanced grafting solutions, encouraging dentists to incorporate these materials into routine practice and thereby stimulating market growth.

Market Segmentation

• Based on the type, the market is segmented into allograft, demineralized allograft, synthetic graft & xenograft.
• Based on the product, the market is segmented into bio-oss, grafton, and osteograf.
• Based on the application, the market is segmented into implant bone regeneration, periodontal defect regeneration, ridge augmentation, sinus lift, and socket preservation.

Xenograft Segment to Grow at a Considerable Market Share

Xenograft is the single largest segment leading the global dental bone graft substitutes market. Xenografts hold a dominant market share due to their high clinical reliability, strong osteoconductive properties, and long-standing acceptance in dental practice, particularly in implant-related procedures. Products such as bovine-derived grafts are widely used for implant bone regeneration, ridge augmentation, and sinus lift procedures, as they closely mimic human bone structure and support predictable bone formation.

Additionally, xenografts offer advantages over autografts and allografts, including ready availability, reduced surgical time, elimination of donor-site morbidity, and consistent material quality, making them highly preferred by clinicians. Their compatibility with leading commercial products like Bio-Oss, which is extensively adopted globally, further strengthens their dominance. As dental implant procedures continue to rise globally especially in North America and Europe xenografts remain the most utilized and revenue-generating segment, positioning them as the key driver of overall market leadership in the global dental bone graft substitutes landscape.

Implant Bone Regeneration: A Key Segment in Market Growth

The Implant Bone Regeneration segment is emerging as the key growth driver within the global dental bone graft substitutes market. This segment accounts for a significant portion of market revenue due to the rapidly increasing adoption of dental implants as the preferred solution for missing teeth. Implant procedures often require sufficient bone volume and density for successful osseointegration, making bone graft substitutes essential for achieving predictable clinical outcomes. Advances in biomaterials, including products like Bio-Oss, Grafton, and OsteoGraf, have enhanced the efficacy and safety of bone grafting in implant procedures, increasing clinician confidence and patient acceptance.

Furthermore, the rising prevalence of edentulism, aging populations, and growing awareness of aesthetic and functional dental restoration are driving higher demand for implant-based treatments. This segment benefits from widespread application across dental hospitals, clinics, and specialized implant centers, particularly in regions such as North America and Europe, where implant procedures are increasingly routine. Additionally, emerging markets in Asia-Pacific are witnessing rapid growth in implant adoption due to improving dental infrastructure and affordability, further propelling this segment. Given the combination of clinical necessity, technological innovation, and demographic trends, implant bone regeneration is positioned as the primary contributor to market expansion, making it the most attractive and high-growth application segment in the dental bone graft substitutes landscape.

Regional Outlook

The global dental bone graft substitutes market is further divided by geography, including North America (the US and Canada), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), and the Rest of the World (the Middle East & Africa, and Latin America).

North America Region to Hold a Substantial Growth Rate

In North America, the US dominates the global Dental Bone Graft Substitutes market,, holding a major share due to its a combination of high procedure volumes, advanced healthcare infrastructure, and strong adoption of innovative dental technologies. The US has a well-established network of dental clinics, hospitals, and specialty implant centers, which facilitates widespread access to bone grafting procedures, including implant bone regeneration, ridge augmentation, and periodontal defect repair. A significant factor contributing to market dominance is the high prevalence of dental disorders such as periodontitis, edentulism, and alveolar bone loss among the adult and aging population, which increases the demand for bone graft substitutes.

Furthermore, reimbursement coverage for dental procedures under private insurance and Medicare/Medicaid programs encourages patients to opt for advanced treatments, including the use of synthetic, xenograft, and allograft grafting materials. The presence of major market players such as Zimmer Biomet, Geistlich Pharma, Dentsply Sirona, and BioHorizons in the region enhances product availability, continuous innovation, and clinician awareness, further consolidating market leadership. Additionally, the US serves as a hub for research and development, driving adoption of advanced biomaterials like Bio-Oss, Grafton, and OsteoGraf, which are widely used in implant and periodontal applications. Collectively, these factors position North America as the dominant country in the global dental bone graft substitutes market, contributing the largest revenue share and setting trends for clinical practices and technological advancements globally.

Market Players Outlook

The major companies operating in the global dental bone graft substitutes market include Dentsply Sirona, Geistlich Pharma AG, Institut Straumann AG (Straumann Group), Medtronic plc, ZimVie Inc., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisitions to expand their businesses and develop innovative products to maintain their market positioning.

Recent Development

• In February 2025, Keystone Dental obtained regulatory approval for DynaGraft Zero, the first fully synthetic bone graft substitute showing clinical effectiveness comparable to autogenous bone in ridge augmentation.
• In January 2024, Straumann Group launched NeoCera, a synthetic ceramic bone graft substitute with enhanced osteoblast adhesion for improved bone regeneration.
• In March 2024, Geistlich Biomaterials introduced Bio?Oss Flex, a malleable xenograft with improved handling, removing the need for membrane fixation in certain procedures.
• In April 2024, Zimmer Biomet Dental received FDA clearance for RegenerOss Plus, a biphasic calcium phosphate material with low-dose growth factor to support faster healing.
• In June 2024, Nobel Biocare partnered with Desktop Health to develop 3D?printed titanium?reinforced bone graft scaffolds, reducing procedure time.
• In August 2024, Dentsply Sirona expanded its Symbios bone graft line with an injectable putty?form xenograft optimized for sinus lift procedures.
• In October 2024, BioHorizons launched MinerOss AI, the first bone graft substitute powered by AI to optimize particle size based on defect morphology.
• In December 2024, Medtronic Dental Division introduced Infuse Dental Matrix, adapting their rhBMP?2 controlled?release technology for dental use.

The Report Covers

• Market value data analysis for 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global dental bone graft substitutes market. Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.